Metformin as firstline treatment for type 2 diabetes: are we sure?
Level V
Where this comes from
- Record sourced from PubMed, PMID 26747716.
- Also identified by DOI 10.1136/bmj.h6748.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Rémy Boussageon and colleagues ask whether metformin is bringing practical benefit to patients and question the focus on surrogate measures.
Medical subject headings
- Diabetes Mellitus, Type 2
- Hypoglycemic Agents
- Metformin